Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Financial — Nicole Stout is a Key Opinion Consultant: BSN Medical Consultant to the National Institutes of Health, Rehabilitation Medicine Department* Consultant to Survivorship Solutions LLC Nonfinancial — Chair, Oncology Specialty Council of the American Board of Physical Therapy Specialties
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Nicole L. Stout, DPT, CLT-LANA, FAPTA
Dr. Nicole L. Stout is a research assistant professor in the School of Medicine, Department of Hematology/Oncology at West Virginia University Cancer Institute and with the School of Public Health, Department of Health Policy, Management, and Leadership. She also serves as the associate director of the WVU Cancer Institute's Survivorship Program, where she coordinates the…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. Exercise Evidence Review: Time Course During Phases of Cancer Treatment and Survivorship
Cancer treatment occurs over a protracted time period, often months to years. The need for exercise varies depending on where on the care continuum the patient is. Evidence will be reviewed to guide interventions during the prehabilitation time period, postoperative time period, through adjuvant treatment, and throughout the duration of the survivor’s life span.
2. Exercise Evidence Review: Disease-Specific Considerations
Exercise prescription requires an understanding of the evidence across different disease states. Specific nuances of cancer type and treatment regimens warrant different considerations to achieve individualized and impactful exercise prescription.
3. Exercise Evidence Review: Functional Morbidity and Targeted Exercise Prescription
Evidence for exercise interventions that target common functional impairments related to cancer treatment and its side effects is strong. Issues such as fatigue, lymphedema, depression, myelosuppression, bone density loss, joint arthralgias, lean mass depletion, and others require targeted exercise prescription to achieve optimal outcomes.
4. Exercise Dosing: Frequency, Intensity, Time, and Type
The exercise prescription should be dosed appropriate to the individual’s needs and with consideration for disease type and treatment side effects. Indications for aerobic conditioning or resistive exercise as well as the level of intensity of exercise interventions may differ based on presenting treatment factors.
5. Safety Considerations With Exercise Prescription
Safety considerations are paramount to implementing effective exercise prescription for the individual undergoing cancer treatment or with a history of cancer. Altered blood counts, osseous fragility, deconditioning, and a host of other treatment-related factors should be considered in designing a safe exercise program.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Fill out the form below to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.